Therapeutic effects of adropin on glucose tolerance and substrate utilization in diet-induced obese mice with insulin resistance.

Mol Metab · 2015 · PMC4354928 · PMID 25830094

Europe PMC DOI

hedged sentences

0.0700

closest p · 1.4× alpha

0.0700

boldest claim

The sentences

showed a trendP = 0.07so close (0.05 < p ≤ 0.1)

When the individual levels of substrate oxidation were calculated, adropin-treated mice showed a trend (P = 0.07) of an increase in glucose oxidation and a decrease (P = 0.1) in fatty acid oxidation ( Figure 3 C and D, “pre-INS/GLU”).

also in 53,322 other papers

a strong trendno p-value reported

Interestingly, we found that the hepatic malonyl-CoA level in adropin-treated DIO exhibited a strong trend towards decrease (nmole/g; adr.: 1.4 ± 0.1 vs. veh.: 2.5 ± 0.7).

also in 5,725 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.